Ayman E. Abdelaziz, Ahmed A. Shokeir, Basem I. Awad, Amira Awadalla, A.M. Abdelghany, Omali Y. El-Khawaga. Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways. // Biomaterials and Biosystems. – 2026. – DOI: 10.1016/j.bbiosy.2026.100147. – URL: https://doi.org/10.1016/j.bbiosy.2026.100147
Ayman E. Abdelaziz, Ahmed A. Shokeir, Basem I. Awad, Amira Awadalla, A.M. Abdelghany, & Omali Y. El-Khawaga (2026). Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways. Biomaterials and Biosystems. https://doi.org/10.1016/j.bbiosy.2026.100147
Ayman E. Abdelaziz, et al. “Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways.” Biomaterials and Biosystems, 2026. doi:10.1016/j.bbiosy.2026.100147.
@article{Abdelaziz2026,
title = {Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways},
author = {Abdelaziz, Ayman E. and Shokeir, Ahmed A. and Awad, Basem I. and Awadalla, Amira and Abdelghany, A.M. and El-Khawaga, Omali Y.},
journal = {Biomaterials and Biosystems},
year = {2026},
doi = {10.1016/j.bbiosy.2026.100147},
url = {https://doi.org/10.1016/j.bbiosy.2026.100147}
}